Client Acquisition Criteria for Q3 & Q4 of 2022.

1. Helen M. Banks, Chairman
Corporate Real Estate License # 397864
Stealth Corporate Real Estate License # 9001756
TREC Real Estate Brokers License # 246967
713-705-1598 | helenbanks@ticigroup.com
We have six types of funds available with the following
criteria;
FOR A CONFIDENTIAL DISCUSSION CONTACT:
Assets you or your clients may be considering for
disposition now or in the future.
Principals or Exclusive Representatives Only.
Submit now for Q3 2022 & Q4 2022 Closing
CLIENT ACQUISITION CRITERIA
Healthcare & Bio Life Science Real Estate
1. Smaller properties – Top 50 MSA: Class A+ - B+; Single tenant; National or regional credit. Absolute NNN; 8+ year
lease term with market rent bumps. 6.0% CAP & above. Minimum price of $3,000,000.
2. Medical/Retail. Single or Multi-tenant Properties or Portfolios - Entire US: Class A+ - B+; strong tenant credit;
5-20 year lease term with market rent bumps.NNN&AbsoluteNet;Value-add&Stabilized.6%CAP&above.Priced$3,000,000.00
- $20,000,000.00 each.
3. Bio Life Science - CA, Denver, Raleigh Durham, Houston, Seattle, Phoenix, Boston, Philadelphia, NY & NJ: Class
A; Single tenant preferred; strong tenant credit;10- 20 year lease term with annualrent bumps. NNN & Absolute Net. 6% CAP &
above. Priced $10,000,000.00 and up.
4. Medium sized properties or portfolios - US: ClassA- B+; Single or Multi- tenant; strong tenant credit;3 - 20 yearleaseterm
with marketrent bumps.Value-add & Stabilized. 5.5% CAP & above. Priced $3,000,000.00 - $20,000,000.00 each.
5. Larger properties or portfolios - US: Class A; Single or Multi-tenant; strong tenant credit rating, 8+ year lease terms
with annual increases in rent. 5.5% CAP & above. Minimum price of $20,000,000.00 – No limit.
6. Development Sponsor Equity or JV - Select Markets: DeNovo facilities for Developers/Investors with demonstrated
history and strong credit tenants.
7. Development/JV - BTS DeNovo facilities - US:
8. Others on a case by case basis.
Disposition Tenant Representation
Capital Markets Acquisition
19 21